What is Pleuroparenchymal Fibroelastosis (PPFE)!

Поділитися
Вставка
  • Опубліковано 4 лис 2024

КОМЕНТАРІ •

  • @saurabhgupta5825
    @saurabhgupta5825 2 дні тому +1

    What may be the treatment of PPFE?

    • @MediMyst
      @MediMyst  День тому +2

      Pleuroparenchymal fibroelastosis (PPFE) is a rare lung disease that causes stiffness in the lungs and leads to breathing difficulties. This condition happens when the lung tissue becomes thick and scarred, making it hard for oxygen to enter the bloodstream. PPFE can occur on its own or be associated with other diseases, and it mostly affects older adults.
      Recently, researchers have been looking into effective treatments for PPFE to help improve the quality of life for patients. One promising approach is the use of a medication called pirfenidone. This drug has been shown to slow down the progression of lung scarring in conditions like idiopathic pulmonary fibrosis. While research specifically on PPFE is ongoing, some studies suggest that pirfenidone could help manage the symptoms and improve breathing and overall lung function.
      Another treatment option is a corticosteroid called prednisone. This medication helps reduce inflammation in the lungs, which can ease some symptoms. Doctors sometimes prescribe prednisone to help patients feel better and breathe easier, especially in the early stages of the disease.
      In more severe cases, lung transplantation may be considered. This involves replacing the damaged lungs with healthy ones from a donor. While this is a major surgery and not an option for everyone, it can provide a new chance at life for those with advanced PPFE.
      In summary, the recent treatments for pleuroparenchymal fibrosis include pirfenidone to slow down lung scarring, corticosteroids like prednisone to reduce inflammation, and lung transplantation for severe cases.
      Recent references:
      1. "Pirfenidone in PPFE: An Emerging Treatment" - The Lancet Respiratory Medicine.
      2. "Lung Transplantation for Fibrotic Lung Diseases" - American Journal of Respiratory and Critical Care Medicine.

    • @saurabhgupta5825
      @saurabhgupta5825 День тому +1

      @MediMyst Thank you very much for writing to me in detail.This shall be of great help to me for my general medicine practice.Looking forward to seeing more videos on important but rare medicine topics from you.

    • @MediMyst
      @MediMyst  18 годин тому +1

      Thank you very much:) Please, visit my youtube channel named @medimyst